Paxalisib Combination Shows Early Responses in TNBC
Kazia Therapeutics reported early efficacy signals from a small cohort of metastatic triple-negative breast cancer patients treated with paxalisib combined with pembrolizumab and chemotherapy, with five of six evaluable patients achieving objective responses and…
